Dabur India names Mohit Burman as new Chairman

Published On 2022-08-13 09:30 GMT   |   Update On 2022-08-13 09:30 GMT
Advertisement

New Delhi: Dabur India has announced that Amit Burman has stepped down as the company's Chairman and Mohit Burman has taken over as the Non-Executive Chairman. Amit Burman would continue to be the Non-Executive Director of the company, according to a regulatory filing.

Mohit Burman has been appointed as the Non-Executive Chairman for five years with effect from August 11. He is currently the Non-Executive Vice Chairman of the company.
Advertisement
Besides, the company has appointed Saket Burman as the Non-Executive Vice Chairman for five years.

Amit took on the responsibilities as the CEO of Dabur Foods in 1999 and forayed into the processed foods business with a range of ethnic cooking pastes & chutneys and packaged fruit juices. Amit stepped down as the CEO of Dabur Foods when the company was merged into Dabur India Ltd in July 2007. He was then appointed the Vice Chairman of Dabur India Ltd. He took charge as the Chairman of Dabur India Ltd in 2019. Amit started his career at Dabur's Industrial Engineering Department where he was responsible for induction of machinery, method improvements, manpower reduction and improving product packaging.

Amit holds a MBA degree from University of Cambridge, a M.Sc. degree in Industrial Engineering from Columbia University, USA and a B.Sc. degree in Industrial Engineering from Lehigh University, Bethlehem, PA, USA.  

In the financial year ended March 2022, Dabur India's revenue was at Rs 8,179.50 crore.  
Presently, Dabur India has four brands in its kitty having an annual turnover of Rs 1,000 crore and above -- Dabur Amla, Dabur Vatika, Dabur Red Paste and juice brand Real.
Besides, it has two brands -- Dabur Honey and Dabur Chyawanprash -- that have an annual turnover of more than Rs 500 crore.

Read also: Dabur India eyes strong Ayurvedic healthcare products demand

Tags:    
Article Source : with inputs

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News